Sulfasalazine or enteral diets containing fish oil or oligosaccharides attenuate chronic colitis in rats.
: Recent studies have suggested that n-3 fatty acids from fish oil (FO) as well as short-chain fatty acids may attenuate some of the gut injury and inflammationassociated ulcerative colitic (UC). The objectives of this study were to (a) assess the antiinflammatory activity of sulfasalazine (SAZ), a drug known to be effective in the treatment of human UC in a model of chronic granulomatous colitis in rats and (b) determine whether enteral diets supplemented with either FO or two indigestible oligosaccharides (fructooligosaccharide, FOS; xylooligosaccharide, XOS) could attenuate the inflammation observed in a model of chronic granulomatous colitis. In one series of experiments, female Lewis rats were randomized into three groups consisting of a sham-operated control group, a colitic group, and a colitic group in which rats were given oral sulfasalazine (SAZ) immediately after induction of colitis and continued for 3 weeks. Chronic granulomatous colitis with liver and spleen inflammation was induced by subserosal (intramural) injection of purified peptidoglycan-polysaccharide (PG/PS) into the distal colon. Sham-operated rats were injected with human serum albumin. All rats received standard lab chow. In a second series of experiments, female Lewis rats were randomized into six groups consisting of four colitic groups fed enteral diets, a colitic group fed chow, and a sham-operated group fed a control enteral diet. Enteral diets (300 kcal/kg/day) contained either FO, FOS/ gum arabic, XOS/gum arabic, or no bioactive ingredient (control diet). All rats were fed for 1 week before induction of colitis. Rats consumed the diets for 3 additional weeks before being killed. SAZ significantly attenuated the PG/PS-induced increases in myeloperoxidase (MPO) activity as well as significantly reduced the PG/PS-induced increases in liver and spleen weights. Control (enteral diet) as well as the FO and XOS diets significantly attenuated the increase in colon weight when compared with chow-fed rats. We also found that the FO and XOS diets significantly attenuated the PG/PS-induced increases in colonic MPO activity and colon weight. The FOS and XOS diets significantly attenuated the PG/PS-induced increases in liver weights when compared with PG/PS + chow-fed animals. The antiinflammatory activity of these diets was confirmed by means of histological inspection showing an inhibition of inflammation and maintenance of crypt cell integrity. These results demonstrate that a complete enteral diet supplemented with either FO, FOS, or XOS exhibited antiinflammatory activity that was similar in efficacy to the known antiinflammatory drug SAZ in this model of colitis.